CN1145027C - 测定流体标本中至少一种分析物存在的分析化验装置和方法 - Google Patents
测定流体标本中至少一种分析物存在的分析化验装置和方法 Download PDFInfo
- Publication number
- CN1145027C CN1145027C CNB998110566A CN99811056A CN1145027C CN 1145027 C CN1145027 C CN 1145027C CN B998110566 A CNB998110566 A CN B998110566A CN 99811056 A CN99811056 A CN 99811056A CN 1145027 C CN1145027 C CN 1145027C
- Authority
- CN
- China
- Prior art keywords
- sample
- detection zone
- passage
- antibody
- analyte
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000004458 analytical method Methods 0.000 title claims abstract description 43
- 238000000034 method Methods 0.000 title claims description 53
- 238000001514 detection method Methods 0.000 claims abstract description 275
- 239000012530 fluid Substances 0.000 claims abstract description 111
- 239000012491 analyte Substances 0.000 claims abstract description 110
- 210000004369 blood Anatomy 0.000 claims abstract description 72
- 239000008280 blood Substances 0.000 claims abstract description 71
- 238000012546 transfer Methods 0.000 claims description 180
- 238000006243 chemical reaction Methods 0.000 claims description 107
- 239000003153 chemical reaction reagent Substances 0.000 claims description 65
- 239000007788 liquid Substances 0.000 claims description 50
- 210000002381 plasma Anatomy 0.000 claims description 48
- 150000001875 compounds Chemical class 0.000 claims description 37
- 239000000020 Nitrocellulose Substances 0.000 claims description 31
- 229920001220 nitrocellulos Polymers 0.000 claims description 31
- 230000004044 response Effects 0.000 claims description 26
- 230000009471 action Effects 0.000 claims description 24
- 230000000747 cardiac effect Effects 0.000 claims description 24
- 102000013394 Troponin I Human genes 0.000 claims description 18
- 108010065729 Troponin I Proteins 0.000 claims description 18
- 230000015572 biosynthetic process Effects 0.000 claims description 16
- 210000002966 serum Anatomy 0.000 claims description 13
- 239000000376 reactant Substances 0.000 claims description 11
- 210000002700 urine Anatomy 0.000 claims description 3
- 210000003743 erythrocyte Anatomy 0.000 abstract description 34
- 238000000926 separation method Methods 0.000 abstract description 17
- 238000012360 testing method Methods 0.000 abstract description 13
- 239000000758 substrate Substances 0.000 abstract description 12
- 230000037361 pathway Effects 0.000 abstract 2
- 239000000523 sample Substances 0.000 description 256
- 239000010408 film Substances 0.000 description 170
- 239000000126 substance Substances 0.000 description 75
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 62
- 239000000047 product Substances 0.000 description 52
- 239000000463 material Substances 0.000 description 39
- 239000000427 antigen Substances 0.000 description 36
- 102000036639 antigens Human genes 0.000 description 36
- 108091007433 antigens Proteins 0.000 description 36
- 229960002685 biotin Drugs 0.000 description 31
- 235000020958 biotin Nutrition 0.000 description 31
- 239000011616 biotin Substances 0.000 description 31
- 238000013461 design Methods 0.000 description 30
- 239000010931 gold Substances 0.000 description 29
- 229910052737 gold Inorganic materials 0.000 description 29
- 239000003550 marker Substances 0.000 description 28
- 239000000243 solution Substances 0.000 description 28
- 108010090804 Streptavidin Proteins 0.000 description 26
- 239000012528 membrane Substances 0.000 description 24
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 23
- 238000002372 labelling Methods 0.000 description 23
- 239000012982 microporous membrane Substances 0.000 description 22
- 238000004587 chromatography analysis Methods 0.000 description 20
- 230000008901 benefit Effects 0.000 description 19
- 239000011324 bead Substances 0.000 description 18
- 230000002829 reductive effect Effects 0.000 description 18
- 230000000890 antigenic effect Effects 0.000 description 17
- 102000004190 Enzymes Human genes 0.000 description 16
- 108090000790 Enzymes Proteins 0.000 description 16
- 229940088598 enzyme Drugs 0.000 description 16
- 238000003018 immunoassay Methods 0.000 description 16
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 15
- 230000008569 process Effects 0.000 description 14
- 238000003745 diagnosis Methods 0.000 description 12
- 230000035945 sensitivity Effects 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 230000006872 improvement Effects 0.000 description 11
- 239000002245 particle Substances 0.000 description 11
- 108090001008 Avidin Proteins 0.000 description 10
- 238000003556 assay Methods 0.000 description 10
- 238000001914 filtration Methods 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- 239000002184 metal Substances 0.000 description 10
- 229910052751 metal Inorganic materials 0.000 description 10
- 239000007864 aqueous solution Substances 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 210000001124 body fluid Anatomy 0.000 description 8
- 239000010839 body fluid Substances 0.000 description 8
- 239000007795 chemical reaction product Substances 0.000 description 8
- 238000010276 construction Methods 0.000 description 8
- 230000037029 cross reaction Effects 0.000 description 8
- 239000000975 dye Substances 0.000 description 8
- 229910052709 silver Inorganic materials 0.000 description 8
- 239000004332 silver Substances 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 238000011144 upstream manufacturing Methods 0.000 description 7
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 6
- 238000004108 freeze drying Methods 0.000 description 6
- 230000036039 immunity Effects 0.000 description 6
- 230000002452 interceptive effect Effects 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 6
- 230000003595 spectral effect Effects 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 102000016349 Myosin Light Chains Human genes 0.000 description 5
- 108010067385 Myosin Light Chains Proteins 0.000 description 5
- 239000012472 biological sample Substances 0.000 description 5
- 230000000903 blocking effect Effects 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 229920006267 polyester film Polymers 0.000 description 5
- 238000007639 printing Methods 0.000 description 5
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 4
- 239000000956 alloy Substances 0.000 description 4
- 229910045601 alloy Inorganic materials 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000007547 defect Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 210000005003 heart tissue Anatomy 0.000 description 4
- 239000000976 ink Substances 0.000 description 4
- 239000013642 negative control Substances 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 239000002002 slurry Substances 0.000 description 4
- 239000010409 thin film Substances 0.000 description 4
- ZXKXJHAOUFHNAS-FVGYRXGTSA-N (S)-fenfluramine hydrochloride Chemical compound [Cl-].CC[NH2+][C@@H](C)CC1=CC=CC(C(F)(F)F)=C1 ZXKXJHAOUFHNAS-FVGYRXGTSA-N 0.000 description 3
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 3
- 102000007469 Actins Human genes 0.000 description 3
- 108010085238 Actins Proteins 0.000 description 3
- 206010002383 Angina Pectoris Diseases 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- 241000283707 Capra Species 0.000 description 3
- 102000004420 Creatine Kinase Human genes 0.000 description 3
- 108010042126 Creatine kinase Proteins 0.000 description 3
- 102000030914 Fatty Acid-Binding Human genes 0.000 description 3
- 102000007390 Glycogen Phosphorylase Human genes 0.000 description 3
- 108010046163 Glycogen Phosphorylase Proteins 0.000 description 3
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 3
- 102000004903 Troponin Human genes 0.000 description 3
- 108090001027 Troponin Proteins 0.000 description 3
- 102000004987 Troponin T Human genes 0.000 description 3
- 108090001108 Troponin T Proteins 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 239000007767 bonding agent Substances 0.000 description 3
- 229940098773 bovine serum albumin Drugs 0.000 description 3
- 239000013068 control sample Substances 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000002405 diagnostic procedure Methods 0.000 description 3
- 230000008030 elimination Effects 0.000 description 3
- 238000003379 elimination reaction Methods 0.000 description 3
- 108091022862 fatty acid binding Proteins 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 238000007710 freezing Methods 0.000 description 3
- 230000008014 freezing Effects 0.000 description 3
- 150000002343 gold Chemical class 0.000 description 3
- 208000019622 heart disease Diseases 0.000 description 3
- 229920000669 heparin Polymers 0.000 description 3
- 230000008676 import Effects 0.000 description 3
- 230000000302 ischemic effect Effects 0.000 description 3
- 208000010125 myocardial infarction Diseases 0.000 description 3
- 230000016087 ovulation Effects 0.000 description 3
- 239000013618 particulate matter Substances 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 230000035935 pregnancy Effects 0.000 description 3
- 238000012113 quantitative test Methods 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- -1 silver ions Chemical class 0.000 description 3
- 238000010561 standard procedure Methods 0.000 description 3
- 239000011550 stock solution Substances 0.000 description 3
- 239000012780 transparent material Substances 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 2
- 108010015776 Glucose oxidase Proteins 0.000 description 2
- 239000004366 Glucose oxidase Substances 0.000 description 2
- 241000725303 Human immunodeficiency virus Species 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 102000003992 Peroxidases Human genes 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- 210000004883 areola Anatomy 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 239000013060 biological fluid Substances 0.000 description 2
- 230000006287 biotinylation Effects 0.000 description 2
- 238000007413 biotinylation Methods 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000001427 coherent effect Effects 0.000 description 2
- 230000009918 complex formation Effects 0.000 description 2
- 238000013016 damping Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003365 glass fiber Substances 0.000 description 2
- 229940116332 glucose oxidase Drugs 0.000 description 2
- 235000019420 glucose oxidase Nutrition 0.000 description 2
- 108010046301 glucose peroxidase Proteins 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000009533 lab test Methods 0.000 description 2
- 239000003973 paint Substances 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 238000004080 punching Methods 0.000 description 2
- 238000007348 radical reaction Methods 0.000 description 2
- 239000008279 sol Substances 0.000 description 2
- 238000004381 surface treatment Methods 0.000 description 2
- 210000002845 virion Anatomy 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102000003846 Carbonic anhydrases Human genes 0.000 description 1
- 108090000209 Carbonic anhydrases Proteins 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 241000025470 Clusia rosea Species 0.000 description 1
- 229920000965 Duroplast Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 230000005875 antibody response Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000009933 burial Methods 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000012850 discrimination method Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-N ethanesulfonic acid Chemical class CCS(O)(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-N 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000003317 immunochromatography Methods 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 238000011900 installation process Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000012229 microporous material Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- HEGSGKPQLMEBJL-UHFFFAOYSA-N n-octyl beta-D-glucopyranoside Natural products CCCCCCCCOC1OC(CO)C(O)C(O)C1O HEGSGKPQLMEBJL-UHFFFAOYSA-N 0.000 description 1
- HEGSGKPQLMEBJL-RKQHYHRCSA-N octyl beta-D-glucopyranoside Chemical compound CCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HEGSGKPQLMEBJL-RKQHYHRCSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 210000001187 pylorus Anatomy 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012764 semi-quantitative analysis Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
- G01N33/54387—Immunochromatographic test strips
- G01N33/54388—Immunochromatographic test strips based on lateral flow
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
- G01N33/54387—Immunochromatographic test strips
- G01N33/54388—Immunochromatographic test strips based on lateral flow
- G01N33/54389—Immunochromatographic test strips based on lateral flow with bidirectional or multidirectional lateral flow, e.g. wherein the sample flows from a single, common sample application point into multiple strips, lanes or zones
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4712—Muscle proteins, e.g. myosin, actin, protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/795—Porphyrin- or corrin-ring-containing peptides
- G01N2333/805—Haemoglobins; Myoglobins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- G01N2333/91205—Phosphotransferases in general
- G01N2333/9123—Phosphotransferases in general with a nitrogenous group as acceptor (2.7.3), e.g. histidine kinases
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/25125—Digestion or removing interfering materials
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measurement Of Radiation (AREA)
- Analysing Materials By The Use Of Radiation (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/130,164 | 1998-08-06 | ||
| US09/130,164 US6171870B1 (en) | 1998-08-06 | 1998-08-06 | Analytical test device and method for use in medical diagnoses |
| US09/353,188 | 1999-07-14 | ||
| US09/353,190 | 1999-07-14 | ||
| US09/353,190 US6214629B1 (en) | 1998-08-06 | 1999-07-14 | Analytical test device and method for use in medical diagnoses |
| US09/353,188 US6410341B1 (en) | 1998-08-06 | 1999-07-14 | Analytical test device and method for use in medical diagnoses |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2004100039525A Division CN1250970C (zh) | 1998-08-06 | 1999-08-06 | 分析化验装置和方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1318151A CN1318151A (zh) | 2001-10-17 |
| CN1145027C true CN1145027C (zh) | 2004-04-07 |
Family
ID=27383975
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB998110566A Expired - Fee Related CN1145027C (zh) | 1998-08-06 | 1999-08-06 | 测定流体标本中至少一种分析物存在的分析化验装置和方法 |
| CNB2004100039525A Expired - Fee Related CN1250970C (zh) | 1998-08-06 | 1999-08-06 | 分析化验装置和方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2004100039525A Expired - Fee Related CN1250970C (zh) | 1998-08-06 | 1999-08-06 | 分析化验装置和方法 |
Country Status (12)
Families Citing this family (56)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6673562B2 (en) * | 2000-08-24 | 2004-01-06 | Spectral Diagnostics, Inc. | Differential immunoassay |
| EP1947459A3 (en) * | 2000-08-24 | 2008-09-24 | Nanogen, Inc. | Differential immunoassay |
| SE0003662D0 (sv) * | 2000-10-11 | 2000-10-11 | Pharmacia Diagnostics Ab | Assay method and kit therefor |
| WO2002052263A1 (en) * | 2000-12-22 | 2002-07-04 | Bio A.R.T. Bvba | Flow through assay device, diagnostic kit comprising said assay device and use of said assay device in the detection of an analyte present in a sample |
| DE60218695T2 (de) * | 2001-08-09 | 2007-11-15 | Matsushita Electric Industrial Co., Ltd., Kadoma | Biosensoren und messverfahren |
| CA2488933C (en) * | 2002-04-23 | 2016-11-01 | Home Access Health Corporation | Quantitative analysis of a biological sample of unknown quantity |
| US7611670B2 (en) * | 2002-04-23 | 2009-11-03 | Home Access Health Corporation | Quantitative analysis of a biological sample of unknown quantity |
| US7279134B2 (en) * | 2002-09-17 | 2007-10-09 | Intel Corporation | Microfluidic devices with porous membranes for molecular sieving, metering, and separations |
| US7256053B2 (en) | 2002-10-24 | 2007-08-14 | Nanogen, Inc. | Diagnostic device for analyte detection |
| AU2003278040A1 (en) * | 2002-10-24 | 2004-05-13 | Spectral Diagnostics Inc. | Diagnostic device |
| EP1664781B1 (en) * | 2003-09-22 | 2013-05-08 | Quidel Corporation | Devices for the detection of multiple analytes in a sample |
| WO2005095967A1 (en) * | 2004-03-23 | 2005-10-13 | Quidel Corporation | Hybrid phase lateral flow assay |
| US20060078471A1 (en) * | 2004-10-12 | 2006-04-13 | Witty Thomas R | Apparatus and method for a precision flow assay |
| WO2006098804A2 (en) * | 2005-03-11 | 2006-09-21 | Chembio Diagnostic Systems, Inc. | Dual path immunoassay device |
| US7189522B2 (en) * | 2005-03-11 | 2007-03-13 | Chembio Diagnostic Systems, Inc. | Dual path immunoassay device |
| US7794656B2 (en) * | 2006-01-23 | 2010-09-14 | Quidel Corporation | Device for handling and analysis of a biological sample |
| US7871568B2 (en) * | 2006-01-23 | 2011-01-18 | Quidel Corporation | Rapid test apparatus |
| US20120003727A1 (en) * | 2006-03-10 | 2012-01-05 | Javanbakhsh Esfandiari | Immunoassay Device for Detecting Antibodies and Antigens |
| US20080115798A1 (en) * | 2006-06-08 | 2008-05-22 | Donald Frank Rainey | Ultra-size cosmetic applicator having enhanced surface area |
| US8008034B2 (en) * | 2006-10-13 | 2011-08-30 | Theranos, Inc. | Reducing optical interference in a fluidic device |
| US20090042737A1 (en) * | 2007-08-09 | 2009-02-12 | Katz Andrew S | Methods and Devices for Correlated, Multi-Parameter Single Cell Measurements and Recovery of Remnant Biological Material |
| CN103226150B (zh) * | 2007-10-30 | 2015-01-21 | 松下健康医疗器械株式会社 | 分析用仪器和使用该分析用仪器的分析装置及分析方法 |
| US20110287461A1 (en) * | 2008-05-27 | 2011-11-24 | Zbx Corporation | Enzymatic analytical membrane, test device and method |
| US20100022916A1 (en) | 2008-07-24 | 2010-01-28 | Javanbakhsh Esfandiari | Method and Apparatus for Collecting and Preparing Biological Samples for Testing |
| WO2010022537A1 (zh) * | 2008-08-26 | 2010-03-04 | 红电医学科技股份有限公司 | 流体检测试片的基板 |
| US20110318822A1 (en) * | 2008-08-29 | 2011-12-29 | Chih-Wei Hsieh | Analytical strip |
| JP5243609B2 (ja) * | 2008-09-16 | 2013-07-24 | 紅電醫學科技股▲分▼有限公司 | 組み合わせ式テストストリップ |
| TWI402500B (zh) * | 2008-09-19 | 2013-07-21 | Actherm Inc | 流體檢測試片 |
| JP5162031B2 (ja) | 2008-10-09 | 2013-03-13 | 紅電醫學科技股▲分▼有限公司 | 液体の検査方法 |
| AU2008362976B2 (en) | 2008-10-17 | 2013-03-28 | Actherm Inc. | Liquid test strip and the method |
| JP2012505417A (ja) | 2008-10-17 | 2012-03-01 | 紅電醫學科技股▲分▼有限公司 | 体液試験ストリップ及びその方法 |
| US9720003B2 (en) | 2008-12-22 | 2017-08-01 | Koninklijke Philips Electronics N.V. | Assay for Troponin I using magnetic labels |
| US10203310B2 (en) | 2009-01-26 | 2019-02-12 | Detectachem Llc | Chemical detection of substances by utilizing a sample medium impregnated with solid test chemicals |
| US8453525B2 (en) * | 2009-02-09 | 2013-06-04 | Healthpoint Diagnostix, Inc. | Plasma sample collection device |
| WO2010102294A1 (en) * | 2009-03-06 | 2010-09-10 | President And Fellows Of Harvard College | Methods of micropatterning paper-based microfluidics |
| KR101329846B1 (ko) * | 2009-03-23 | 2013-11-14 | 액텀 아이엔씨. | 분석 스트립 및 그의 제조 방법 |
| CN102313802B (zh) * | 2010-07-09 | 2014-04-23 | 上海荣盛生物药业有限公司 | 检测抗原或抗体的组件及其用途 |
| WO2012011074A2 (en) | 2010-07-22 | 2012-01-26 | Hach Company | Lab-on-a-chip for alkalinity analysis |
| JP5650970B2 (ja) * | 2010-09-28 | 2015-01-07 | 富士フイルム株式会社 | 検査装置およびその制御方法、並びに検査用反応容器 |
| US8603835B2 (en) | 2011-02-10 | 2013-12-10 | Chembio Diagnostic Systems, Inc. | Reduced step dual path immunoassay device and method |
| CN103917643B (zh) | 2011-11-22 | 2020-06-05 | 西门子医疗保健诊断公司 | 包含用于复原为校准和/或质量控制溶液的干燥试剂的设备，及其生产和使用方法 |
| KR101280054B1 (ko) * | 2012-05-31 | 2013-06-28 | 에스디 바이오센서 주식회사 | 현장진단 면역크로마토그래피용 동결건조 접합체 구조물, 이를 이용하는 면역분석용 키트 및 상기 키트를 이용하는 분석방법 |
| US9180449B2 (en) | 2012-06-12 | 2015-11-10 | Hach Company | Mobile water analysis |
| WO2014081460A1 (en) * | 2012-11-20 | 2014-05-30 | Kisner Mark | Chemical sequencing and control to expand and enhance detection capabilities utilizing a colorimetric test |
| USD768872S1 (en) | 2012-12-12 | 2016-10-11 | Hach Company | Cuvette for a water analysis instrument |
| US9482675B1 (en) * | 2013-07-31 | 2016-11-01 | University Of Kentucky Research Foundation | Methods and systems for prognosis and diagnosis of brain damage |
| SG11201608278WA (en) | 2014-04-02 | 2016-10-28 | Chembio Diagnostic Systems Inc | Immunoassay utilizing trapping conjugate |
| US10258984B2 (en) * | 2014-06-16 | 2019-04-16 | Koninklijke Philips N.V. | Cartridge for fast sample intake |
| US9885699B2 (en) * | 2014-07-31 | 2018-02-06 | Becton, Dickinson And Company | Methods for processing whole blood samples, and compositions for use in practicing the same |
| US20160116466A1 (en) | 2014-10-27 | 2016-04-28 | Chembio Diagnostic Systems, Inc. | Rapid Screening Assay for Qualitative Detection of Multiple Febrile Illnesses |
| US9981264B2 (en) | 2014-11-04 | 2018-05-29 | Grace Bio-Labs, Inc. | Nitrocellulose extrusion for porous film strips |
| JP2018506718A (ja) | 2015-01-30 | 2018-03-08 | ヒューレット−パッカード デベロップメント カンパニー エル．ピー．Ｈｅｗｌｅｔｔ‐Ｐａｃｋａｒｄ Ｄｅｖｅｌｏｐｍｅｎｔ Ｃｏｍｐａｎｙ， Ｌ．Ｐ． | 診断装置 |
| US10725031B1 (en) | 2017-04-26 | 2020-07-28 | Conquerab Inc. | Reflux device for detection of analytes in samples |
| CN107389911A (zh) * | 2017-07-12 | 2017-11-24 | 柳州康云互联科技有限公司 | 用于移动端的快速分离检测传感器 |
| AU2019284882A1 (en) * | 2018-06-12 | 2021-01-07 | Nowdiagnostics, Inc. | Device and method for collecting plasma |
| US11766369B1 (en) | 2020-09-30 | 2023-09-26 | Douglas Dillon | Single use protective cover for patient transport device |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3029579C2 (de) | 1980-08-05 | 1985-12-12 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren und Mittel zur Abtrennung von Plasma oder Serum aus Vollblut |
| US4987065A (en) | 1983-07-05 | 1991-01-22 | Enzo Biochem, Inc. | In vivo labelling of polynucleotide sequences |
| DE3445816C1 (de) | 1984-12-15 | 1986-06-12 | Behringwerke Ag, 3550 Marburg | Flaechenfoermiges diagnostisches Mittel |
| US4753776A (en) | 1986-10-29 | 1988-06-28 | Biotrack, Inc. | Blood separation device comprising a filter and a capillary flow pathway exiting the filter |
| US5079142A (en) | 1987-01-23 | 1992-01-07 | Synbiotics Corporation | Orthogonal flow immunoassays and devices |
| US4774192A (en) | 1987-01-28 | 1988-09-27 | Technimed Corporation | A dry reagent delivery system with membrane having porosity gradient |
| CA1303983C (en) * | 1987-03-27 | 1992-06-23 | Robert W. Rosenstein | Solid phase assay |
| US5120643A (en) | 1987-07-13 | 1992-06-09 | Abbott Laboratories | Process for immunochromatography with colloidal particles |
| US5096809A (en) | 1988-07-25 | 1992-03-17 | Pacific Biotech, Inc. | Whole blood assays using porous membrane support devices |
| US5114890A (en) | 1988-09-02 | 1992-05-19 | Teledyne Industries, Inc. | Zirconium-containing coating composition |
| US5135716A (en) | 1989-07-12 | 1992-08-04 | Kingston Diagnostics, L.P. | Direct measurement of HDL cholesterol via dry chemistry strips |
| US5075078A (en) | 1989-10-05 | 1991-12-24 | Abbott Laboratories | Self-performing immunochromatographic device |
| US4993092A (en) | 1989-11-13 | 1991-02-19 | Weeks David B | Patient carrier cover and method |
| US5110724A (en) | 1990-04-02 | 1992-05-05 | Cholestech Corporation | Multi-analyte assay device |
| US5843691A (en) * | 1993-05-15 | 1998-12-01 | Lifescan, Inc. | Visually-readable reagent test strip |
| US6171870B1 (en) * | 1998-08-06 | 2001-01-09 | Spectral Diagnostics, Inc. | Analytical test device and method for use in medical diagnoses |
-
1999
- 1999-08-06 CN CNB998110566A patent/CN1145027C/zh not_active Expired - Fee Related
- 1999-08-06 AT AT99940165T patent/ATE237807T1/de not_active IP Right Cessation
- 1999-08-06 CN CNB2004100039525A patent/CN1250970C/zh not_active Expired - Fee Related
- 1999-08-06 AU AU54208/99A patent/AU764444B2/en not_active Ceased
- 1999-08-06 DE DE69906986T patent/DE69906986T2/de not_active Expired - Lifetime
- 1999-08-06 MX MXPA01001384A patent/MXPA01001384A/es active IP Right Grant
- 1999-08-06 KR KR1020017001614A patent/KR100604510B1/ko not_active IP Right Cessation
- 1999-08-06 CA CA002339599A patent/CA2339599A1/en not_active Abandoned
- 1999-08-06 WO PCT/EP1999/005712 patent/WO2000008466A2/en active IP Right Grant
- 1999-08-06 JP JP2000564049A patent/JP2002522767A/ja active Pending
- 1999-08-06 EP EP99940165A patent/EP1102989B1/en not_active Expired - Lifetime
-
2001
- 2001-02-06 US US09/777,549 patent/US6673628B2/en not_active Expired - Fee Related
- 2001-11-30 HK HK01108465A patent/HK1039518A1/xx active IP Right Revival
-
2003
- 2003-11-21 AU AU2003262455A patent/AU2003262455A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| KR100604510B1 (ko) | 2006-07-25 |
| DE69906986D1 (de) | 2003-05-22 |
| WO2000008466A9 (en) | 2000-06-29 |
| JP2002522767A (ja) | 2002-07-23 |
| CA2339599A1 (en) | 2000-02-17 |
| CN1519563A (zh) | 2004-08-11 |
| WO2000008466A2 (en) | 2000-02-17 |
| WO2000008466A3 (en) | 2000-05-18 |
| EP1102989A2 (en) | 2001-05-30 |
| ATE237807T1 (de) | 2003-05-15 |
| CN1318151A (zh) | 2001-10-17 |
| DE69906986T2 (de) | 2004-02-12 |
| EP1102989B1 (en) | 2003-04-16 |
| US6673628B2 (en) | 2004-01-06 |
| HK1039518A1 (en) | 2002-04-26 |
| MXPA01001384A (es) | 2002-11-29 |
| KR20010085338A (ko) | 2001-09-07 |
| AU5420899A (en) | 2000-02-28 |
| CN1250970C (zh) | 2006-04-12 |
| AU2003262455A1 (en) | 2003-12-18 |
| US20010039059A1 (en) | 2001-11-08 |
| AU764444B2 (en) | 2003-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1145027C (zh) | 测定流体标本中至少一种分析物存在的分析化验装置和方法 | |
| CN1201527A (zh) | 具有传导阻片的对置部件分析装置 | |
| CN1142868A (zh) | 具有用于调节施加试剂的屏障的测定装置 | |
| CN1103919C (zh) | 物质的测定方法及试片 | |
| CN100351990C (zh) | 滞留层析和蛋白质芯片排列在生物学和医药上的应用 | |
| CN1137316A (zh) | 阻断流分析装置 | |
| CN1262667C (zh) | 利用颗粒标记物检测分析物 | |
| Akama et al. | Wash-and amplification-free digital immunoassay based on single-particle motion analysis | |
| CN1124524A (zh) | 由可相互对折叠合的构件构成的色谱测定装置 | |
| CN1217189C (zh) | 测定全血样品中白细胞个数的方法 | |
| CN1564945A (zh) | 快速诊断装置,分析方法及多功能缓冲液 | |
| CN1715932A (zh) | 用于处理液体的微结构平台和方法 | |
| CN1182394C (zh) | 特异结合分析方法及用于其的特异结合分析装置 | |
| CN1282378A (zh) | 利用颗粒标记物检测分析物 | |
| CN101031798A (zh) | 侧向流系统和测定 | |
| CN1309769A (zh) | 分析仪 | |
| CN1582394A (zh) | 分子的快速灵敏检测 | |
| CN1129790C (zh) | 测定物质的方法和用于该方法中的测定试剂 | |
| CN1610831A (zh) | 通过检测肿瘤发生和转移相关蛋白的糖基化变化诊断癌症的方法及使用其诊断癌症的试剂盒 | |
| CN101065671A (zh) | 传感器装置 | |
| CN1186513A (zh) | 多阵列、多特异性的电化学发光检验 | |
| CN1370278A (zh) | 分析盒和液体输送控制装置 | |
| US20110065594A1 (en) | Identification of discriminant proteins through antibody profiling, methods and apparatus for identifying an individual | |
| CN1628247A (zh) | 过滤型蛋白芯片 | |
| CN101035429A (zh) | 定量侧向流系统和测定 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |